7516
J . Org. Chem. 1998, 63, 7516-7519
Notes
Sch em e 1
Extr a or d in a r y F or m a tion of a Novel
Bu ta d ien e Der iva tive,
(Z,E)-1-(2-Na p h th ylm eth yloxyca r bon yl-
a m in o)-2,4-bis(4-n itr op h en yl)bu ta d ien e,
a n d Su bsequ en t Isom er iza tion in to th e
Cor r esp on d in g (E,E)-Isom er
Min Li,† Leela Kar, and Michael E. J ohnson*
Center for Pharmaceutical Biotechnology and
Department of Medicinal Chemistry & Pharmacognosy
(M/ C 781), University of Illinois at Chicago,
Chicago, Illinois 60612-7231
Received February 10, 1998
Phosphorus-containing peptide analogues have been
widely utilized in designs of novel protease inhibitors
because of their ability to mimic the transition state of
enzymatic catalyses.
R-Amino phosphonates were most frequently incor-
porated in such designs;1-4 on the other hand, R-amino
phosphinates received less attention. In our ongoing
program of de novo design of thrombin inhibitors, we find,
as supported by molecular modeling, that the structural
features of R-amino phosphinates could be beneficial to
our goal of developing noncovalent active site inhibitors.
The R-amino phosphinates utilized in our design as the
key building blocks are N-CBZ-protected [1-amino-2-(4-
substituted-phenyl)ethyl]phenylphosphinates (1), which
were synthesized by adopting a procedure of Chen and
Dan5 (Scheme 1). In a typical preparation, benzyl
carbamate was treated with (4-nitrophenyl)acetaldehyde6
and dichlorophenylphosphine in acetic acid to give a good
yield (∼60%) of the desired 4-nitrophenyl compound 2.
When the benzyl carbamate was substituted by 2-naph-
thylmethyl carbamate in the same reaction under identi-
cal conditions, however, much less material was obtained.
Moreover, an unexpected compound 4 was formed as the
major product (a relative 80%, mol/mol) present in the
crude material, while the desired compound 3 was
produced in 20% yield. The major product was purified
careful examination of the 1H NMR spectrum (in DMSO-
d6) of 4 revealed the presence of an “impurity”, and it
was soon discovered that the peaks of this “impurity”
increased as those of 4 decreased (Figure 1) while the
NMR solution of the product stood at room temperature.
An important characteristic of this transformation (with
a half-life of ∼4 months) is that the total number of the
new peaks is equal to that of the old one (4) and, more
importantly, the new scalar coupling constants appear
to remain the same. This indicates that some key
structural features of the original product 4 were pre-
served and the transformation is an intramolecular
event, such as isomerization. Compound 4 appears to
be stable in its solid form when kept in the dark at room
temperature. However, under somewhat elevated tem-
perature, even the solid underwent transformation.
A scrutiny of several possible mechanisms led us to
the structure of (Z,E)-butadiene 4 shown in Figure 2 as
the original product, which slowly isomerizes into the
1
(E,E)-butadiene 5 (Figure 2). The results of 1D H NMR
(Figure 1) and 2D COSY experiments7 support the basic
configuration of the product (4) as a butadiene. The
important connectivities between neighboring protons of
1 and 2, 3, and 4 are clearly evidenced in the COSY
spectrum,7 and the same spectrum also shows that these
connectivities are preserved in the isomer (5), as indi-
cated by cross-peaks of 1′-2′ and 3′-4′. The coupling
constant between protons 3 and 4 was found to be 16 Hz,
leading to the assignment of a trans (E) configuration
for the second double bond. The ROESY experiments,7
on the other hand, provided crucial through-space cou-
pling data, rendering possible the unambiguous assign-
ment of the configurations and conformations for both 4
and its isomer, 5. Some key ROESY cross-peaks for
1
from the crude material and its H NMR (Figure 1, top)
showed a distinctively different pattern from that of the
expected one (3), and elemental analysis revealed a
composition of C28H21N3O6 with no phosphorus present,
in agreement with the mass spectrometric analysis (CI
mode) which showed an [M + 1]+ peak at m/ e 496. A
† Current address: Merck & Co., Inc., WP38-3, P.O. Box 4, West
Point, PA 19486.
(1) Fastrez, J .; J espers, L.; Lison, D.; Renard, M.; Sonveaux, E.
Tetrahedron Lett. 1989, 30, 6861-6864.
(2) Cheng, L.; Goodwin, C. A. Tetrahedron Lett. 1991, 32, 7333-
7336.
(3) Wang, C.-L. J .; Taylor, T. L.; Mical, A. J .; Spitz, S.; Reilly, T. M.
Tetrahedron Lett. 1992, 33, 7667-7670.
(4) Oleksyszyn, J .; Boduszek, B.; Kam, C.-M.; Powers, J . C. J . Med.
Chem. 1994, 37, 226-231.
(5) Chen, R.-Y.; Dan, S.-C. Phosphorus, Sulfur, Silicon 1991, 56,
39-48.
(7) The 2D COSY and ROESY experimental parameters and results
(Figures 3-5) are included in the Supporting Information for this
paper. However, some key ROESY cross-peaks observed in a mixture
of 4 and 5 are summarized in Table 1.
(6) Lethbridge, A.; Norman, R. O. C.; Thomas, C. B. J . Chem. Soc.,
Perkin 1 1973, 35-38.
S0022-3263(98)00242-4 CCC: $15.00 © 1998 American Chemical Society
Published on Web 09/30/1998